Eden Research plc (AIM:EDEN)

Market Cap	14.67M
Revenue (ttm)	4.30M
Net Income (ttm)	-1.91M
Shares Out	533.35M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	800,086
Average Volume	369,798
Open	2.970
Previous Close	2.750
Day's Range	2.933 - 3.482
52-Week Range	2.233 - 5.000
Beta	1.20
RSI	65.89
Earnings Date	May 8, 2025

About Eden Research

Eden Research plc, together with its subsidiaries, develops and sells biopesticides solution for crop protection, animal health, and consumer products industries in the United Kingdom and Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications under the Mevalone and Cedroz brand names. It also offers animal health products, such as companion animal, bio-control, parasite treatments, and insect spray pro...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1995
• Employees: 19
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: EDEN

Financial Performance

In 2024, Eden Research's revenue was 4.30 million, an increase of 34.79% compared to the previous year's 3.19 million. Losses were -1.91 million, -70.64% less than in 2023.